Your session is about to expire
← Back to Search
Radiation
Total Body Irradiation for Blood Cancers
N/A
Waitlist Available
Led By Naamit Gerber, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year post-transplant
Awards & highlights
Study Summary
This trial looks at the safety of using a particular type of radiation therapy to treat blood cancers.
Who is the study for?
Adults over 18 who need a stem cell transplant for blood cancer and require high-dose radiation as part of their treatment. They must be referred by the BMT program, pass pre-transplant tests including lung function and lab work, and not have had previous chest radiation. Pregnant women or prisoners cannot participate.Check my eligibility
What is being tested?
The study is testing the safety of a new way to deliver total body irradiation using VMAT (a type of advanced precision radiotherapy) in patients preparing for stem cell transplants to treat blood cancers.See study design
What are the potential side effects?
Potential side effects may include skin reactions, fatigue, nausea, mouth sores due to radiation exposure; specific risks will depend on individual health status and the intensity of irradiation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year post-transplant
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year post-transplant
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of patients who achieve excellent coverage while sparing the lung
Secondary outcome measures
Cumulative incidence rate of idiopathic pneumonia syndrome
Event Free Survival (EFS)
Occurrence of acute GVHD, transplant related mortality, or mortality in the first 100 days following transplant
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Patients with Hematologic MalgnanciesExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,726 Total Patients Enrolled
Naamit Gerber, MDPrincipal InvestigatorNYU Langone Health
2 Previous Clinical Trials
360 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My treatment plan follows specific guidelines for bone marrow transplant.I am 18 years old or older.I am not pregnant, as confirmed by a urine test.I am referred for full-dose total body irradiation by the BMT program.I have had radiation therapy to my chest area before.I have completed the required tests before a bone marrow transplant.I am having a stem cell transplant with a high-dose radiation treatment.I have had lung function tests as part of my bone marrow transplant evaluation.I am receiving low-dose radiation therapy.My bone marrow transplant team will start my referral for radiation consultation.My HLA type has been confirmed.
Research Study Groups:
This trial has the following groups:- Group 1: Patients with Hematologic Malgnancies
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many applicants are being considered for this research project?
"Correct. The information housed on clinicaltrials.gov reveals that this medical examination, which had its origin on September 22nd 2020, is currently looking for participants. Approximately 35 patients need to be recruited from a single location."
Answered by AI
Are there still opportunities for individuals to participate in the trial?
"The information available on clinicaltrials.gov suggests that enrollment is currently open for this trial, which was originally posted in September of 2020 and most recently updated in November 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger